National Quality Measures Clearinghouse | Cardiovascular disease: Australian Council on Healthcare Standards [2].

Australian Council on Healthcare Standards [2]

* 1. Cardiovascular disease: percentage of inpatients undergoing coronary artery bypass grafts (CABGs) within 24 hours of percutaneous transluminal coronary angioplasty (PCTA) (with or without stenting) in the same admission, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Cardiovascular disease: percentage of inpatients undergoing coronary artery bypass grafts (CABGs) within 24 hours of percutaneous transluminal coronary angioplasty (PCTA) (with or without stenting) in the same admission, during the 6 month time period.


* 2. Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure and atrial fibrillation who have no contraindication to the use of warfarin, who are prescribed warfarin, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure and atrial fibrillation who have no contraindication to the use of warfarin, who are prescribed warfarin, during the 6 month time period.


* 3. Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure who have no contraindications to the use of an ACE Inhibitor (ACEI) or Angiotensin II Receptor Antagonist (A2RA) who are prescribed an ACEI or A2RA, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure who have no contraindications to the use of an ACE Inhibitor (ACEI) or Angiotensin II Receptor Antagonist (A2RA) who are prescribed an ACEI or A2RA, during the 6 month time period.


* 4. Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure who have no contraindications to the use of beta blockers and who are prescribed beta blocker therapy, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure who have no contraindications to the use of beta blockers and who are prescribed beta blocker therapy, during the 6 month time period.


* 5. Cardiovascular disease: percentage of patients discharged with any diagnosis of congestive heart failure who are referred for chronic disease management service that includes physical rehabilitation, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Cardiovascular disease: percentage of patients discharged with any diagnosis of congestive heart failure who are referred for chronic disease management service that includes physical rehabilitation, during the 6 month time period.


* 6. Cardiovascular disease: percentage of patients with acute myocardial infarction (AMI) requiring thrombolysis who receive thrombolytic therapy within 1 hour of presentation to the hospital, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Cardiovascular disease: percentage of patients with acute myocardial infarction (AMI) requiring thrombolysis who receive thrombolytic therapy within 1 hour of presentation to the hospital, during the 6 month time period.


* 7. Cardiovascular disease: percentage of vessels in which percutaneous transluminal coronary angioplasty (PTCA) (with or without stenting) is undertaken where primary success, as defined, is achieved, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Cardiovascular disease: percentage of vessels in which percutaneous transluminal coronary angioplasty (PTCA) (with or without stenting) is undertaken where primary success, as defined, is achieved, during the 6 month time period.